Publications by Type
21 found
Show per page
Peer-Reviewed Publication Types
Brown, Jennifer Anne, Ringera, Isaac Kaumbuthu, Luoga, Ezekiel, Bresser, Moniek, Mothobi, Buoang, Kabundi, Lorraine, Ilunga, Mulume, Mokhele, Kuena, Isaac, Andreas Boy, Tsoaeli, Ntsepiseng, Mbaya, Thomas, Simba, Brenda, Mayogu, Kasasi, Mabula, Elizabeth, Cheleboi, Molisana, Molatelle, Mamello, Kimera, Namvua, Mollel, Getrud Joseph, Sando, David, et al. (2024). Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial [Journal-article]. The Lancet Global Health, 12(8), e1312–e1322. https://doi.org/10.1016/s2214-109x(24)00183-9
Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae185
, Lukau, Blaise, Tlali, Katleho, Motaboli, Lipontso, Kao, Mpho, Kopo, Mathebe, Hänggi, Kathrin, Mokebe, Moleboheng, Naegele, Klaudia, Ayakaka, Irene, Leuzinger, Karoline, Brown, Jennifer A, & Labhardt, Niklaus D. (2024). Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho [Journal-article]. Devendra, Akash, Kohler, Maurus, Letsika, Motlatsi, Khooa, Hape, Motaboli, Lipontso, Lerotholi, Malebanye, AIDS. https://doi.org/10.1097/qad.0000000000003835
, Labhardt, Niklaus D., & Brown, Jennifer A. (2024). HIV viral suppression in children and adolescents two years after transition to dolutegravir: a multicentre cohort study [Journal-article]. Belus, Jennifer M., Johnson, Natalie E., Yoon, Grace H., Trials, 25. https://doi.org/10.1186/s13063-024-08411-3
, Lerotholi, Malebanye, Falgas-Bague, Irene, Lee, Tristan T., Letsoela, Pearl, Magidson, Jessica F., Amstutz, Alain, & Labhardt, Niklaus D. (2024). SMSs as an alternative to provider-delivered care for unhealthy alcohol use: study protocol for Leseli, an open-label randomised controlled trial of mhGAP-Remote vs mhGAP-Standard in Lesotho. Kohler, Maurus, Brown, Jennifer A., Open Forum Infectious Diseases, 11. https://doi.org/10.1093/ofid/ofae013
, Lerotholi, Malebanye, Motaboli, Lipontso, Mokete, Moliehi, Chammartin, Frédérique, & Labhardt, Niklaus D. (2024). Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciad390
, Lerotholi M, Motaboli L, Mokete M, Labhardt ND, & Brown JA. (2023). Two-year outcomes of treatment-experienced adults after programmatic transitioning to dolutegravir: longitudinal data from the VICONEL HIV cohort in Lesotho. Brown, Jennifer A., Nsakala, Bienvenu L., Mokhele, Kuena, Rakuoane, Itumeleng, Muhairwe, Josephine, Urda, Lorena, Amstutz, Alain, HIV medicine, 23(3), 287–293. https://doi.org/10.1111/hiv.13189
, Klimkait, Thomas, & Labhardt, Niklaus D. (2022). Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: a prospective cohort study in Lesotho (DO-REAL study). Clinical Infectious Diseases, 72(12), 2175–2183. https://doi.org/10.1093/cid/ciaa411
, Kusejko, Katharina, Nguyen, Huyen, Chaudron, Sandra E., Kadelka, Claus, Turk, Teja, Böni, Jürg, Perreau, Matthieu, Klimkait, Thomas, Yerly, Sabine, Battegay, Manuel, Rauch, Andri, Ramette, Alban, Vernazza, Pietro, Bernasconi, Enos, Cavassini, Matthias, Günthard, Huldrych F., & Kouyos, Roger D. (2021). Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men. Other Publications
Brown, Jennifer A., Motaboli, Lipontso, Lerotholi, Malebanye, Kohler, Maurus, Hänggi, Kathrin, Mokete, Moliehi, Chakely, Makobefo G., Kao, Mpho, Kopo, Mathebe, Mokebe, Moleboheng, Nsakala, Bienvenu L., Lukau, Blaise, Ayakaka, Irene, Amstutz, Alain, Ehmer, Jochen, Klimkait, Thomas, Glass, Tracy R., Muhairwe, Josephine, Chammartin, Frédérique, et al. (2024). Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 - cohort description, test volumes, predictors of viraemia, and the road ahead [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.12.24304025
Emergence of Acquired Dolutegravir Resistance in Treatment-Experienced People with HIV in Lesotho [Posted-content]. Elsevier BV. https://doi.org/10.2139/ssrn.4683840
, Lukau, Blaise, Tlali, Katleho, Motaboli, Lipontso, Kao, Mpho, Kopo, Mathebe, Hänggi, Kathrin, Mokebe, Moleboheng, Naegele, Klaudia, Ayakaka, Irene, Leuzinger, Karoline, Brown, Jennifer A., & Labhardt, Niklaus Daniel. (2024). Kopo, M., Lejone, T. I., PLoS Med, 20(1), e1004150. https://doi.org/10.1371/journal.pmed.1004150
, Glass, T. R., Kao, M., Brown, J. A., Seiler, O., Muhairwe, J., Moletsane, N., Labhardt, N. D., & Amstutz, A. (2023). Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: the PEBRA cluster-randomized trial. Seiler, O., Kopo, M., Kao, M., Lejone, T. I., AIDS Res Treat, 2023, 8124192. https://doi.org/10.1155/2023/8124192
, Glass, T. G., Brown, J. A., Labhardt, N. D., & Amstutz, A. (2023). HIV care preferences among young people living with HIV in Lesotho: a secondary data analysis of the PEBRA cluster randomized trial. Seiler, O., Kopo, M., Kao, M., Lejone, T. I., Tschumi, N., Glass, T. R., Brown, J. A., Labhardt, N. D., & Amstutz, A. (2022). HIV care preferences among young people living with HIV in Lesotho: A secondary data analysis of the PEBRA cluster randomized trial [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.07.29.22278205
Brown, J. A., Nsakala, B. L., Mokhele, K., Rakuoane, I., Muhairwe, J., Glass, T. R., Amstutz, A., HIV Med, 24(2), 153–162. https://doi.org/10.1111/hiv.13352
, Belus, J. M., Klimkait, T., & Labhardt, N. D. (2022). Dolutegravir in real life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho. Chaudron, S. E., Leemann, C., Kusejko, K., Nguyen, H., J Infect Dis, 226(7), 1256–1266. https://doi.org/10.1093/infdis/jiac166
, Marzel, A., Huber, M., Böni, J., Perreau, M., Klimkait, T., Yerly, S., Ramette, A., Hirsch, H. H., Rauch, A., Calmy, A., Vernazza, P., Bernasconi, E., Cavassini, M., Metzner, K. J., et al. (2022). A systematic molecular epidemiology screen reveals numerous human immunodeficiency virus (HIV) type 1 superinfections in the Swiss HIV Cohort Study. Kusejko, K., J Acquir Immune Defic Syndr, 90(4), e4–e12. https://doi.org/10.1097/qai.0000000000002949
, Chaudron, S. E., Nguyen, H., Battegay, M., Bernasconi, E., Boni, J., Huber, M., Calmy, A., Cavassini, M., Egle, A., Grabmeier-Pfistershammer, K., Haas, B., Hirsch, H., Klimkait, T., Öllinger, A., Perreau, M., Ramette, A., Babouee Flury, B., et al. (2022). Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics. Scherrer, R., Pilot Feasibility Stud, 8(1), 61. https://doi.org/10.1186/s40814-022-01019-x
, Lejone, T. I., Kopo, M., Motaboli, L., Mothobi, B., Amstutz, A., Deml, M. J., Lerotholi, M., & Labhardt, N. D. (2022). eHealth supported multi-months dispensing of antiretroviral therapy: a mixed-methods preference assessment in rural Lesotho. PLoS One, 17(5), e0268100. https://doi.org/10.1371/journal.pone.0268100
, Lerotholi, M., Kopo, M., Kao, M., Lukau, B., Nsakala, B., Chejane, N., Motaboli, L., Lee, T., Barnabas, R., Shapiro, A. E., van Heerden, A., Lejone, T. I., Amstutz, A., Brown, J. A., Heitner, J., Belus, J. M., Chammartin, F., & Labhardt, N. D. (2022). Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): study protocol of a cluster-randomized trial. Brown, J. A., Mbunkah, H. A., Lejone, T. I., Ringera, I., Cheleboi, M., Klimkait, T., Metzner, K. J., Gunthard, H. F., Labhardt, N. D., Kouyos, R. D., & Open Forum Infect Dis, 8(5), ofab046. https://doi.org/10.1093/ofid/ofab046
(2021). Emergence of human immunodeficiency virus-1 drug resistance during the 3-month World Health Organization-recommended enhanced adherence counseling period in the CART-1 cohort study. Thorball, C. W., Borghesi, A., Bachmann, N., von Siebenthal, C., Vongrad, V., Turk, T., Neumann, K., Beerenwinkel, N., Bogojeska, J., Roth, V., Kok, Y. L., Parbhoo, S., Wieser, M., Böni, J., Perreau, M., Klimkait, T., Yerly, S., Battegay, M., Rauch, A., et al. (2019, December 6). Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/19013763
Turk, Teja, eLife, 6, e28721. https://doi.org/10.7554/elife.28721
, Kadelka, Claus, Böni, Jürg, Yerly, Sabine, Aubert, Vincent, Klimkait, Thomas, Battegay, Manuel, Bernasconi, Enos, Calmy, Alexandra, Cavassini, Matthias, Furrer, Hansjakob, Hoffmann, Matthias, Günthard, Huldrych F., Kouyos, Roger D., & Swiss HIV Cohort Study. (2017). Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.